Long-Circulating Liposomal Delivery System Targeting at PDGFR-β Enhances the Therapeutic Effect of IFN-α on Hepatic Fibrosis-Reference-Cited by-同舟云学术

Long-Circulating Liposomal Delivery System Targeting at PDGFR-β Enhances the Therapeutic Effect of IFN-α on Hepatic Fibrosis

Published:2017-08-18 Issue:20 Volume:23 Page:
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

Li Qinghua¹,Yu Qi²,Ju Jing³,You Tiangeng¹,Yan Zhiqiang⁴,Nan Xiangli⁴,Zhong Jie²,Zhou Jing E.⁴

Affiliation:

1. Department of Hepatopancreatobiliary and Gastroenterology, Shanghai East Hospital, Tongji University, 1800 Yuntai Road, Pudong New District, Shanghai 200123, China

2. Department of Hepatopancreatobiliary and Gastroenterology, Shanghai East Hospital, Tongji University, 1800 Yuntai Road, Shanghai 200123, China

3. Department of Biochemistry and Molecular Biology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, China

4. Institute of Biomedical Engineering and Technology, School of Chemistry and Molecular Engineering, East China Normal University, 3663 Zhongshan Road (N), Shanghai 200062, China

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic Stellate Cell Targeting Using Peptide-Modified Biologicals;Methods in Molecular Biology;2023

2. A new approach based on CXCR4-targeted combination liposomes for the treatment of liver fibrosis;Biomaterials Science;2022

3. Nanovesicles for hepatic-targeted drug delivery;Applications of Nanovesicular Drug Delivery;2022

4. Long Circulation of PEG-TRAIL Improves Anti-Hepatic Fibrosis Effect of TRAIL Via Targeting Activated Hepatic Stellate Cells;Frontiers in Materials;2021-06-17

5. Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo;Journal of Cellular and Molecular Medicine;2018-12-27